Fact Source: Daishin Securities / Report Date: June 30, 2026
Investment Opinion & Target Price: BUY (Maintain) / 78,000 KRW (Maintain)
Key Momentum: Relief from China VBP 2.0 implementation delays heading into Q3 order normalization, coupled with structural EPS upgrades driven by aggressive share buybacks and cancellations.
📊 1. [Valuation Indicators & Investment Metrics Analysis]
- Investment Opinion & Target Price Trend: Maintained the ‘BUY’ rating and the 6-month target price of KRW 78,000. The target price was calculated by applying a Target P/E of 11.0x to the 2026F EPS of KRW 7,102, representing a 20% discount relative to the global peer average excluding Straumann.
- Current Valuation Assessment: The stock is currently trading at a mid-6x 2026F P/E and a low-5x 12-month forward P/E, remaining deeply undervalued. Headwinds such as China’s VBP delays, slow domestic demand, and currency weaknesses have been mostly priced in, offering high multi-year expansion potential once Chinese orders recover.
- Key Financial Metrics & Valuation Forecasts:
- Revenue: 2024A: KRW 408B ➡️ 2025A: KRW 346B ➡️ 2026F: KRW 371B ➡️ 2027F: KRW 426B
- Operating Profit: 2024A: KRW 98B ➡️ 2025A: KRW 64B ➡️ 2026F: KRW 86B ➡️ 2027F: KRW 104B
- P/E (Price-to-Earnings Ratio): 2024A: 9.5x ➡️ 2025A: 31.2x ➡️ 2026F: 6.5x ➡️ 2027F: 5.5x
- P/B (Price-to-Book Ratio): 2024A: 1.2x ➡️ 2025A: 0.9x ➡️ 2026F: 0.6x ➡️ 2027F: 0.5x
- ROE (Return on Equity): 2024A: 14.3% ➡️ 2025A: 2.9% ➡️ 2026F: 10.5% ➡️ 2027F: 10.8%
🚀 2. [Market Opportunities (TAM) & Detailed Earnings Estimates]
- 2026F Annual Performance Forecasts:
- Annual Revenue: Estimated at KRW 371.0B (+7% YoY).
- Annual Operating Profit: Modeled at KRW 86.4B (+35% YoY) with an expected OPM of 23%, pointing to an early confirmation of profit recovery.
- Quarterly Performance & Operational Drivers:
- 1Q26 Results: Logged revenue of KRW 71.4B (-7% YoY) and operating profit of KRW 15.9B (+65% YoY, OPM 22%). Despite weak domestic demand and VBP implementation gaps, GPM reached 76.7% thanks to low-cost raw material processing and manufacturing efficiencies.
- 2Q26 Estimates: Projected revenue of KRW 85.2B (+4% YoY) and operating profit of KRW 17.2B (+11% YoY, OPM 20%). While the peak GPM from Q1 will normalize, the company maintains the structure to defend an OPM around 20%.
- Regional Demand and Order Backlog Dynamics:
- China Market: Cumulative export volume from January to May remains soft at USD 32.75M (-24% YoY). However, with China’s VBP 2.0 anticipated for a July notice and August execution, distributor POs (Purchase Orders) are poised for a significant rebound post-Q3. 2026 Chinese revenue is modeled at KRW 149.6B (+13% YoY).
- Other Regions: Steady top-line growth persists across broader Asian regions, while European revenue is seeing sequential improvements driven by a turnaround in Russian POs.
- Share Buyback and Cancellation Execution:
- Executed consecutive treasury share cancellations of 0.81M shares in February and 1.63M shares in March, accumulating roughly 2.44M canceled shares. This reduced the total outstanding share count to 8.62M, structurally boosting future EPS curves. A new KRW 60.0B share buyback trust agreement has also been signed to fortify downside support.
📝 Editor’s Comment (by K-STOCK Editor)
Dentium’s current equity compression reflects an overextended macro discount rather than eroded business fundamentals. As shown across recent quarterly estimates, Dentium successfully sustained a 20% OPM floor via raw material sourcing changes, even under the near-term overhang of China’s VBP 2.0 delays. The pivotal catalyst for global institutional investors to track is the official timeline for China’s VBP 2.0 notice, expected within July. The moment distributor purchasing orders normalize in Q3, Dentium’s China revenue stream (modeled at KRW 149.6B for 26E) will experience sharp operational acceleration. Furthermore, the cancellation of 2.44M treasury shares executed earlier this year has permanently compressed the share base, magnifying the EPS trajectory upon cyclical recovery. Supported by zero near-term heavy CapEx obligations and a new KRW 60.0B buyback trust facility, the structural downside for the stock appears firmly protected.
📢 Disclaimer & Source Information Source: This content has been newly structured and written based on financial facts and data from officially published securities reports.
Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!
